| Mar 31 2020 |
CARES Act Provides Vital Financial Support for Health Care Providers on COVID-19 Front Lines |
Robinson & Cole LLP |
| Mar 31 2020 |
Corporate Authority for Extraordinary Delivery of Care Decisions |
McDermott Will & Schulte LLP |
| Mar 31 2020 |
The CARES Act From a Health CARE Perspective |
Katten |
| Mar 30 2020 |
UPDATED: New York State Issues Additional Guidance for Emergency Paid Sick Leave Bill (US) |
Squire Patton Boggs (US) LLP |
| Mar 30 2020 |
CMS Sending Hospice Cap Demands Ahead of Schedule |
Sheppard, Mullin, Richter & Hampton LLP |
| Mar 30 2020 |
DOL Guidance Expands Definition of 'Health Care Providers,' Giving Employers a Choice |
Much Shelist, P.C. |
| Mar 30 2020 |
Gov. Evers Relaxes Health Care Provider Licensing Requirements |
von Briesen & Roper, s.c. |
| Mar 30 2020 |
Need to Know: Expansive Health Care Provider Exemption under the FFCRA |
Polsinelli PC |
| Mar 30 2020 |
COVID-19 Update – Ohio Issues FAQs on Health Insurance Flexibility for Employers |
Jackson Lewis P.C. |
| Mar 30 2020 |
Value-Based Payment Arrangements During the COVID-19 Pandemic |
Epstein Becker & Green, P.C. |
| Mar 30 2020 |
CARES Act - New Group Health Plan Rules and Relief |
Foley & Lardner LLP |
| Mar 30 2020 |
COVID-19: Federal Agencies Prepare to Distribute Unprecedented Federal Financial Relief for the Health Care Industry |
Foley & Lardner LLP |
| Mar 30 2020 |
Responding to Government Inquires Related to Price Gouging During the COVID-19 Pandemic |
Robinson & Cole LLP |
| Mar 30 2020 |
COVID-19 von Briesen Task Force Resource: Current Status of Waivers of Federal Fraud & Abuse Laws |
von Briesen & Roper, s.c. |
| Mar 30 2020 |
Trademark Applicant & Chinese IP Agency Fined for Malicious Registration of Coronavirus Related Trademarks |
Schwegman, Lundberg & Woessner, P.A. |
| Mar 30 2020 |
Texas Medical Board Passes Emergency Rules Enforcing Gov. Abbott's Executive Order GA-09, relating to hospital capacity during the Coronavirus disaster |
Foley & Lardner LLP |
| Mar 30 2020 |
Key Health Care Provisions of the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) |
Sheppard, Mullin, Richter & Hampton LLP |
| Mar 30 2020 |
Coronavirus Aid, Relief, And Economic Security Act Of 2020: Telehealth Front and Center |
Sheppard, Mullin, Richter & Hampton LLP |
| Mar 30 2020 |
DOJ Civil Division Highlights False Claims Act Priorities for 2020 |
Squire Patton Boggs (US) LLP |
| Mar 30 2020 |
New Jersey: Designated ‘Health Care Facilities’ to Submit Daily Reports on Capacity, Supplies |
Jackson Lewis P.C. |
| Mar 30 2020 |
EBSA FY 2019 MHPAEA Enforcement |
Proskauer Rose LLP |
| Mar 30 2020 |
CARES Act Provides Financial Relief for Health Care Providers |
Norris McLaughlin P.A. |
| Mar 30 2020 |
CARES Act Provisions Affecting Employee Benefits |
Robinson & Cole LLP |
| Mar 30 2020 |
Defense Production Act: Presidential Directive to GM… What Does it Mean for Industry? |
Wiggin and Dana LLP |
| Mar 30 2020 |
Key Provisions in the CARES Act for Health Care Providers |
von Briesen & Roper, s.c. |
| Mar 30 2020 |
Precautions for Healthcare Providers Sourcing Personal Protective Equipment from Foreign Suppliers |
McDermott Will & Schulte LLP |
| Mar 30 2020 |
Nursing and Rehabilitation Centers Settle Allegations for Billing Unnecessary Rehabilitation Treatments |
Tycko & Zavareei LLP |
| Mar 30 2020 |
CMS Announces Regulatory Flexibility for CLIA Laboratories |
McDermott Will & Schulte LLP |
| Mar 30 2020 |
FDA Issues FAQs on 3D Printing of Medical Devices, Accessories, Components and Parts During the COVID-19 Pandemic |
McDermott Will & Schulte LLP |
| Mar 29 2020 |
Business Tax Benefits in the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) |
von Briesen & Roper, s.c. |
| Mar 29 2020 |
Individual Tax Benefits in the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) |
von Briesen & Roper, s.c. |
| Mar 29 2020 |
UPDATE: US Department of Labor Publishes Further Guidance Concerning Paid Sick Leave and Paid FMLA Leave under FFCRA; Finally Clarifies Small Business Exemption (US) |
Squire Patton Boggs (US) LLP |
| Mar 29 2020 |
Whistleblower Suit Against Pharmaceutical Company Heads to Trial |
Katz Banks Kumin LLP |
| Mar 29 2020 |
Defense Production Act: Presidential Directive to GM What Does it Mean for Industry? |
Wiggin and Dana LLP |
| Mar 29 2020 |
The DOL Defines the “Emergency Responder” and “Health Care Provider” Exemption from FFCRA |
von Briesen & Roper, s.c. |
